Journal of Antimicrobial Chemotherapy (1999) 43, 55-60
© 1999 The British Society for Antimicrobial Chemotherapy
Markedly different rates and resistance profiles exhibited by seven commonly used and newer ß-lactams on the selection of resistant variants of Enterobacter cloacae
a Department of Pharmacy, The Chinese University of Hong Kong, Shatin, Hong Kong; b Department of Microbiology, The Chinese University of Hong Kong, Shatin, Hong Kong; c Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo, NY, USA
Seven ß-lactam antibiotics (cefepime, cefoperazone, ceftazidime, ceftriaxone, cefamandole, imipenem and meropenem) were tested for their potential to select resistance in standard and clinical strains of Enterobacter cloacae (n = 9). The strains were subcultured daily with the test antibiotics at doubling concentrations starting at 0.125 x MIC. Development of resistance throughout the passages was detected by a disc diffusion test. Ceftazidime, ceftriaxone and cefamandole selected resistance at a faster rate than cefoperazone, cefepime and meropenem. Imipenem did not select resistance in the nine strains tested and was the only antibiotic that eradicated all the strains during selection. The resistance patterns of strains selected by meropenem, cefepime and the other cephalosporins were markedly different, although cross-resistance to the early generation cephalosporins was common. The resistance phenotypes of most strains remained stable upon serial passages in antibiotic-free medium. The findings of this study highlight the importance of the choice of antibiotic for therapy not only on the basis of its antibacterial activity, but also on its potential to select resistance to itself and other antibiotics.
* Corresponding author. Tel: +852-2609-7983; Fax: 852-2603-5295; E-mail: ronli{at}cuhk.edu.hk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. E. Cosgrove, K. S. Kaye, G. M. Eliopoulous, and Y. Carmeli Health and Economic Outcomes of the Emergence of Third-Generation Cephalosporin Resistance in Enterobacter Species Arch Intern Med, January 28, 2002; 162(2): 185 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ball, F. Baquero, O. Cars, T. File, J. Garau, K. Klugman, D. E. Low, E. Rubinstein, R. Wise, and T. Consensus Group on Resistance and Prescribing in R Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence J. Antimicrob. Chemother., January 1, 2002; 49(1): 31 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ruiz, A. Jurado, E. Garcia-Mendez, F. Marco, L. Aguilar, M. T. Jimenez de Anta, and J. Vila Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones J. Antimicrob. Chemother., October 1, 2001; 48(4): 545 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Thorburn and D. I. Edwards The effect of pharmacokinetics on the bactericidal activity of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae and the emergence of resistance J. Antimicrob. Chemother., July 1, 2001; 48(1): 15 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Drago, E. De Vecchi, B. Mombelli, L. Nicola, M. Valli, and M. R. Gismondo Activity of levofloxacin and ciprofloxacin against urinary pathogens J. Antimicrob. Chemother., July 1, 2001; 48(1): 37 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Jones Conventional dogma applied to quinolones? Time for a change J. Antimicrob. Chemother., June 1, 2001; 47(6): 893 - 893. [Full Text] [PDF] |
||||
![]() |
D. Xuan, M. Zhong, H. Mattoes, K. Q. Bui, J. McNabb, D. P. Nicolau, R. Quintiliani, and C. H. Nightingale Streptococcus pneumoniae Response to Repeated Moxifloxacin or Levofloxacin Exposure in a Rabbit Tissue Cage Model Antimicrob. Agents Chemother., March 1, 2001; 45(3): 794 - 799. [Abstract] [Full Text] |
||||
![]() |
M. D. Cubbon and R. G. Masterton New quinolones--a fresh answer to the pneumococcus J. Antimicrob. Chemother., December 1, 2000; 46(6): 869 - 872. [Full Text] [PDF] |
||||


